anmeldenFTSE All-Share
5.814,48
PKT
-27,89
PKT
-0,48
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.10.15 | Barclays buy | Citigroup Corp. | |
| 29.10.15 | Shell (ex Royal Dutch Shell) Hold | S&P Capital IQ | |
| 29.10.15 | BAT Equal-Weight | Morgan Stanley | |
| 29.10.15 | Diageo Outperform | Credit Suisse Group | |
| 29.10.15 | GSK Sell | Société Générale Group S.A. (SG) | |
| 28.10.15 | BAT Hold | S&P Capital IQ | |
| 28.10.15 | BP Halten | Independent Research GmbH | |
| 28.10.15 | GSK Neutral | JP Morgan Chase & Co. | |
| 28.10.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 28.10.15 | BP overweight | JP Morgan Chase & Co. | |
| 28.10.15 | BP Neutral | BNP PARIBAS | |
| 28.10.15 | BP Neutral | Goldman Sachs Group Inc. | |
| 28.10.15 | BP buy | UBS AG | |
| 28.10.15 | London Stock Exchange (LSE) Hold | Société Générale Group S.A. (SG) | |
| 28.10.15 | BP Hold | Société Générale Group S.A. (SG) | |
| 27.10.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 26.10.15 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 26.10.15 | BP buy | UBS AG | |
| 26.10.15 | GSK Neutral | JP Morgan Chase & Co. | |
| 26.10.15 | AstraZeneca buy | UBS AG | |
| 23.10.15 | Anglo American neutral | Independent Research GmbH | |
| 23.10.15 | Prudential Neutral | JP Morgan Chase & Co. | |
| 23.10.15 | GSK Neutral | Citigroup Corp. | |
| 23.10.15 | BAT buy | Deutsche Bank AG | |
| 23.10.15 | BP buy | Deutsche Bank AG | |
| 23.10.15 | Shell (ex Royal Dutch Shell) buy | Deutsche Bank AG | |
| 23.10.15 | BP Neutral | BNP PARIBAS | |
| 22.10.15 | AstraZeneca Underweight | Morgan Stanley | |
| 22.10.15 | Sky Neutral | BNP PARIBAS | |
| 22.10.15 | GSK Neutral | BNP PARIBAS | |
| 22.10.15 | Barclays Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.10.15 | Lloyds Banking Group Neutral | Goldman Sachs Group Inc. | |
| 22.10.15 | HSBC Neutral | Goldman Sachs Group Inc. | |
| 21.10.15 | GSK Equal-Weight | Morgan Stanley | |
| 21.10.15 | Rio Tinto buy | Deutsche Bank AG | |
| 21.10.15 | BP Neutral | Goldman Sachs Group Inc. | |
| 21.10.15 | AstraZeneca market-perform | Bernstein Research | |
| 21.10.15 | GSK market-perform | Bernstein Research | |
| 21.10.15 | Vodafone Group buy | UBS AG | |
| 21.10.15 | GSK Neutral | UBS AG |
